SMARCA2 and non-small cell lung carcinoma: These findings indicated that SMARCA2 and SMARCA4 participate in two distinct, functionally complementary chromatin-remodeling complexes and that their expression and cellular localization could serve as useful markers for NSCLC prognosis [9].